Ignite Creation Date:
2024-05-06 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 2:28 PM
Study NCT ID:
NCT05303441
Status:
UNKNOWN
Last Update Posted:
2022-03-31
First Post:
2022-03-09
Brief Title:
The Predictive and Diagnostic Value of Cystatin C and High Sensitive Troponin
Sponsor:
Ankara Diskapi Training and Research Hospital
Organization:
Ankara Diskapi Training and Research Hospital
Study Overview
Official Title:
The Predictive and Diagnostic Value of Using Cystatin C and High Sensitive Troponin Level Together for Diagnosis of ACS in Patients With Chronic Kidney Disease Coming to Emergency Department With Chest Pain
Status:
UNKNOWN
Status Verified Date:
2022-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our study is planning to evaluate patients with chronic kidney disease who come to the emergency department with chest pain Estimated GFR cisGFR with cystatin and estimated GFR creaGFR with creatinine will be calculated Symptoms ECG and troponin values of patients will be evaluated for diagnosis of acute coronary syndrome
Detailed Description:
Our study is planning to evaluate patients with chronic kidney disease who come to the emergency department with chest pain Estimated GFR cisGFR with cystatin and estimated GFR creaGFR with creatinine will be calculated Symptoms ECG and troponin values of patients will be evaluated for diagnosis of acute coronary syndrome and the final diagnosis of AMI will be adjudicated by 2 independent cardiologistsSerial troponin measurements and eGFR values will be proportioned These values the will be evaluated and compared for patients with acute coronary syndromeculprit lesion on conventional coronary angiography and non-ACS ones With these data we aim to facilitate the diagnosis of acute coronary syndromeincrease the specificity and sensitivity of cardiac troponins for the diagnosis of acute coronary syndrome of patients with chronic kidney disease increase the utility of high sensitive troponins for patients with chronic kidney disease Again with these data it is aimed to reduce the number of false negative and false positive diagnosis of acute coronary syndrome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None